A drug for pulmonary fibrosis created using artificial intelligence (AI) is showing early promise in patients.

The current pharmaceutical landscape demands a change in mindset. Success requires balancing speed, cost and quality while ...

The US FDA has granted fast track designation to the novel amanitin-based antibody-drug conjugate (ADC) pamlectabart ...

About Mondego Bio Mondego Bio, headquartered at Portugal's Biocant biotech park, is developing best-in-class PTPN2 inhibitors as a next-generation immuno-oncology strategy. The company's Series A ...

Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing two Phase 2 small-molecule programs for ...

India: Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced ...

In the rapidly evolving pharmaceutical landscape, drug discovery services have become a pivotal axis around which innovation, efficiency and competitiveness rotate. According to a recent market report ...

Preliminary efficacy data, combined with a tolerable safety profile, reinforce the potential of ZW191 in patients with advanced solid tumors, ...

Elevara Medicines secured $70 million in Series A funding to advance ELV001's Phase II trial for rheumatoid arthritis and explore other chronic inflammatory conditions. Pharma investments surge as ...

The peptide lab is designed to produce a range of molecules, including linear peptides, cyclic peptides, and peptide-drug conjugates.